Le Registre des lobbyistes
Nombre total de rapports de communication : 1
Rapports mensuels de communications au cours des 6 derniers mois : 0
| Objets | Détails | Catégories |
|---|---|---|
|
Développement économique, Santé, Infrastructure
|
Engage with the federal government on building Canada's vaccine and biomanufacturing ecosystem.
|
Politique ou Programme
|
|
Développement économique, Santé, Infrastructure
|
Seeking funding from the Strategic Innovation Fund to allow for the construction of facilities to advance Canada’s vaccine and biomanufacturing capabilities.
|
Subvention, Contribution ou autre avantage financier
|
Resilience Biotechnologies (RBI), formerly Therapure Biopharma, is a wholly owned subsidiary of National Resilience, Inc. RBI is an Ontario-based Contract Development and Manufacturing Organization (CDMO) specializing in the development and manufacturing of complex biologics. RBI’s mission is to support for Canadian vaccine and therapeutics production and serve as a long-term partner for Canadian pharmaceutical manufacturing.
Sankalp Vashishtha, Vice President / General Manager
Adresse :
2585 Meadowpine Blvd.
Mississauga, ON L5N 8H9
Canada
Numéro de téléphone :
905-286-6200
Resilience Biotechnologies, Inc. ne possède aucune filiale qui pourrait être directement intéressée au résultat de l'engagement